| Literature DB >> 33841509 |
Jian Liu1, He Zhu1, Li Fu1, Tianmin Xu1.
Abstract
Circular RNAs (circRNAs) are non-coding RNA molecules, and these are differentially expressed in various diseases, including cancer, suggesting that circRNAs can regulate certain diseases. CircRNAs can act as miRNAs sponges, RNA-binding protein (RBP) sponges, and translation regulators, and they can become an important part of the regulation of gene expression. Furthermore, because of their biomedical features in body fluids, such as high abundance, conservation, and stability, circRNAs are seen as potential biomarkers for various cancers. Cervical cancer (CC) is one of the main causes of cancer-related death in women, and there have been a large number of studies that analyze circRNAs as a new object to be evaluated in CC. Therefore, this review, by understanding the role of circRNAs in CC, may create innovative strategies in the future clinical diagnosis, treatment, and prognosis of CC and promote the development of personalized and highly accurate cancer therapy.Entities:
Keywords: cervical cancer; circRNAs; miRNAs sponges; molecular marker; precision medicine
Year: 2021 PMID: 33841509 PMCID: PMC8027469 DOI: 10.3389/fgene.2021.653051
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Different types and functions of circRNAs: (1) According to the source of circRNA, it can be divided into the following categories: circular intronic RNAs (ciRNA) derived from gene introns; exonic circRNA (ecircRNAs) derived from gene exons; intergenic circRNAs derived from breakpoints between known genes; antisense circRNA derived from the antisense strand of a known gene; and sense overlapping circRNA: derived from the same gene locus as the linear transcript. (2) CircRNAs have the following four functions: regulating the transcription of genes; translating proteins; acting as miRNA sponges; and binding functional proteins.
The effects of circRNA on CC cell lines.
| circRNA | miRNA | CC cell lines and Xenograft | Function | Type of detection methods | References |
| circ-0033550 (circRNA-AKT1) | miR-942-5p | HeLa, CaSki, SiHa, C33A, 293T, and H8 cell lines; Male BALB/c nude mice | Promotes cell proliferation and invasion; Increased the volume and weight of xenografts | CCK-8, transwell, colony formation, FISH, Immunofluorescence (IF) staining, dual-luciferase reporter, 5-Ethynyl-2′-deoxyuridine (EdU), RNA pull-down, and RIP assays | |
| circAGFG1 | miR-370-3p | HeLa, C-33A, SiHa, HCC94, and End1/E6E7 (normal cervical cell line) | CircAGFG1 downregulation restrained cell viability, proliferation and migration, and promoted cell apoptosis | loss-of function, bioinformatics analysis, mechanism experiments, and rescue assays | |
| circular RNA hsa_circ_0000515 | miR-326 | Hela and SiHa cell lines; Clean grade female BALB/c nude mice | Hsa_circ_0000515 silencing attenuated cell proliferation and invasion; promoted apoptosis and autophagy; and reduced tumor volume and weight | EdU, Monodansylcadaverine (MDC) staining, flow cytometric, transwell, FISH, RIP, dual-luciferase reporter, and TdT-mediated dUTP-biotin nick end-labeling (TUNEL) staining assays | |
| circular RNA hsa_circ_0023404 | miR-136 | SiHa, C-33a, CaSki, C4-1 and Hela, and human cervical epithelial cells (CerEpiC) | Hsa_circ_0023404 knockdown significantly suppressed cell proliferation and colony formation | CCK-8, transwell, colony formation, cell cycle distribution, and luciferase reporter assays | |
| circCLK3 | miR-320a | SiHa, HeLa, CaSki, C-33A, MS751 cell lines; BALB/c athymic nude mice | Promotes cell proliferation, migration, and invasion. Promoted growth and metastasis of tumor | CCK-8, cell colony, wound healing, transwell migration and invasion, RNA pull-down, RIP, luciferase reporter, and rescue assays | |
| circular RNA HIPK3 | miR-338-3p | SiHa and C-4I cell lines | Circ-HIPK3 silencing inhibited cell proliferation, migration and invasion, while induced apoptosis | CCK-8, cell formation, cell apoptosis, transwell migration and invasion, point mutation, RNA pull-down, luciferase reporter, and rescue assays | |
| circ_0067934 | miR-545 | SiHa, CaSki, Hela, and C4-1 and immortalized cervical epithelium NC104 cell line; BALB/c nude mice | Promotes proliferation, colony formation, migration, invasion, and epithelial-mesenchymal transition of CC cells. Promoted tumor growth | CCK-8, colony proliferation, transwell, and luciferase reporter assays | |
| circEIF4G2 | miR-218 | HeLa, CasKi, C33A, and SiHa cells | CircEIF4G2 knockdown significantly inhibited cell migration and invasion | CCK-8, colony formation, wound healing, transwell migration and invasion, RIP, and dual-luciferase reporter assays | |
| circSLC26A4 (hsa_circ_0132980) | miR-1287-5p | CaSki, SiHa cell lines; Male BALB/c nude mice | CircSLC26A4 silencing inhibited cell proliferation, invasion, and effectively repressed tumor growth | CCK-8, colony proliferation, transwell, RIP, dual-luciferase reporter, and RNA-FISH assays | |
| circSMARCA5 | miR-620 | HeLa, CaSki, SiHa, C33 cell lines, and 293T cells | CircSMARCA5 dramatically inhibited the proliferation and colony-forming abilities of CC cells | Luciferase activity, MTT, and cell invasion assays | |
| circ-ATP8A2 | miR-433 | HeLa and SW756 cell lines | Circ-ATP8A2 knockdown inhibited cell proliferation, migratory and invasive capacities and increased apoptotic cells | CCK-8, acridine orange/ethidium bromide (AO/EB), flow cytometric, transwell, and dual-luciferase reporter assays | |
| circMTO1 | miR-6893 | HeLa, CaSki, C-33A, C-4 II, SiHa and immortalized epithelial cells of human ectocervix Ect1/E6E7 cell lines; NOD-SCID immunodeficient mice | CircMTO1 knockdown suppressed cell migration, invasion, chemoresistance and markedly impaired tumor growth ability | Wound healing, transwell invasion, MTT, TUNEL, and luciferase reporter assays | |
| circRNA hsa_circ_0023404 | miR-5047 | HeLa, SiHa cell lines and 293T cell | Knockdown in HeLa and SiHa cells reduced the number of invaded cells;promotes metastasis of Human Dermal Lymphatic Endothelial Cells (HDLEC) | Transwell invasion, lymphatic vessel, MTT, flow cytometry analysis, and luciferase reporter assays | |
| circ_0005576 | miR-153 | HeLa, SiHa, Caski, C-33A and immortalized cervical epithelium cell lines (HcerEpiC) | Promotes cell proliferation, migration, and invasion | CCK8, colony formation, transwell, RNA pull-down, luciferase reporter, and RIP assays | |
| hsa_circ_0018289 | miR-497 | HeLa, CaSki, SiHa, HT-3,C33A and human epidermal cell (HaCaT); Male BALB/c nude mice | Hsa_circ_0018289 knockdown inhibited cell proliferation, migration and invasion. Decreased the tumor volumes and weights | CCK8, transwell, and luciferase reporter assays | |
| circRNA-000284 | miR-506 | HeLa, CaSki, SiHa, C-33A, and SW756 cell lines | Promotes cell proliferation and invasion | CCK8, transwell, dual-luciferase reporter, and RNA-FISH assays | |
| circular RNA hsa_circ_0000263 | miR-150-5p | HeLa, CaSki, SiHa, C-33A, and SW756 cell lines | Hsa_circ_0000263 downregulation inhibited cell proliferation and migration; promoted cell apoptosis | CCK-8, cell proliferation, transwell, flow cytometric, RIP, and dual-luciferase reporter assays | |
| hsa_circ_0007534 | miR-498 | HeLa, SiHa, and CaSki, and human cervical epithelial immortalized cell line H8 | Hsa_circ_0007534 inhibition impeded cell proliferation and invasion | CCK-8, colony proliferation, transwell, RNA pull-down, and dual-luciferase reporter assays | |
| circAMOTL1 | miR-485-5p | HeLa, CaSki cell lines; BALB/c nude mice (C-33A cells) | Induced cell proliferation and migration. Promoted cervical cancer development | CCK-8, wound healing, transwell, EdU incorporation, RNA pull-down, FISH, and luciferase reporter assays | |
| circ-ITCH | miR-93-5p | SiHa, Caski, HeLa, and C33A cell lines; SPF grade BALB/c nude mice | Inhibited cell proliferation, migration and invasion. Significantly inhibited tumor growth | CCK-8, colony proliferation, transwell, luciferase reporter, and tumor xenograft assays | |
| circ-MYBL2 | miR-361-3p | HeLa, CaSki cell lines | Circ-MYBL2 inhibition suppressed cell proliferation and invasion | CCK-8, colony formation, transwell invasion, RNA pull-down, and luciferase reporter assays | |
| hsa_circ_0075341 | miR-149-5p | SiHa and CaSki cell lines | Promotes cell proliferation and invasion | CCK-8, colony formation, transwell invasion, and dual-luciferase reporter assays | |
| hsa_circ_0001038 | miR-337-3p | HeLa, SiHa, C-33A, SW756, and normal cells (HcerEpiC) | Hsa_circ_0001038 knockdown inhibited cell proliferation, migration and invasion | CCK-8, flow cytometric, transwell, AO/EB staining, loss/gain-of function, and dual-luciferase reporter assays | |
| circRNA8924 | miR-518d-5p/519-5p | SiHa and HeLa cell lines and 293T cells | CircRNA8924 knockdown significantly inhibited cell proliferation, migration and invasion | CCK-8, flow cytometric, transwell, loss/gain-of function, and luciferase reporter assays | |
| circ_0000388 | miR-337-3p | HeLa and SiHa cell lines | Notably enhances cell migration and invasion | CCK-8, TUNEL, wound healing, transwell, RT-PCR, Western blot, RIP, and luciferase reporter assays | |
| circ_103973 | miR-335 | HeLa, CaSki, C33A, and SiHa cell lines | Circ_103973 knockdown promoted cell apoptosis and inhibited cell proliferation | Flow cytometric, MTT, colony formation, dual-luciferase reporter, and RNA pull-down assays | |
| circRNA_0000285 | – | HeLa, SiHa, C4-1, and C-33A and normal cervical epithelium cell line (NC104); NOD/SCID mice | CircRNA_0000285 knockdown inhibited cell proliferation and invasion; inhibited tumor formation and metastasis | CCK-8, cell cycle, and transwell assays | |
| Hsa_circRNA_101996 | miR-8075 | SiHa, C33A, CaSki, and Hela cell lines; BALB/c nude mice | Promotes cell proliferation, migration, and invasion. Led to the decrease of the tumor size and weight | CCK-8, cell invasion, colony formation, and luciferase reporter assays |
FIGURE 2Mechanism of circRNAs in Cervical Cancer: (1) Circ-HIPK3 acts as a competing endogenous RNA of miR-338-3p, via regulating HIF-1α mediated EMT; (2) CircRNA-000284 suppresses the expression of Snail-2 via sponging miR-506; (3) Circ_0067934 modulates EIF3C by sponging miR-545; (4) Circ-0000263, as a competitive endogenous RNA, regulates MDM4 expression by sponging miR-150-5p and may play an important role affecting the expression of p53 gene; (5) Circ-ATP8A2 sponges miR-433 to release its suppression on EGFR expression. CircSMARCA5 modulates miR-432 via the ERK signaling pathway; (6) Hsa_circ_CSPP1 regulates miR-361-5p/ITGB1 in the PI3K-Akt signaling pathway; (7) CircRNA-AKT1 sequesters miR-942-5p to upregulate AKT1; (8) CircAGFG1 enhances the activity of RAF/MEK/ERK pathway by sponging miR-370-3p and further regulating RAF1; and (9) CircMTO1 directly interacts with miR-6893 and their inhibitor enhanced Beclin 1 expression and downregulated p62 level. Hsa_circ_0023404 knockdown can also promote p62 protein levels and attenuate Beclin 1 level.
The potential circRNAs that could be used as biomarkers in clinical application.
| circRNA | miRNA | Target gene | Clinical application | Type of detection methods | References |
| Hsa_circ_0101996 and hsa_circ_0101119 | – | – | The expression of Hsa_circ_0101996 and hsa_circ_0101119 were significantly upregulated in peripheral whole blood from CC patients | RT-qPCR and ROC analysis | |
| circCLK3 | miR-320a | FoxM1 | Significantly correlated with poor tumor differentiation, advanced FIGO stages, and large depth of stromal invasion but was negatively related with OS and disease-free survival of CC patients | qRT-PCR and Kaplan–Meier Plotter analysis | |
| circ_0005576 | miR-153 | KIF20A | Upregulated circ_0005576 was positively associated with advanced FIGO stage, lymph node metastasis, but was negatively related with OS of CC patients | qRT-PCR, Kaplan–Meier Plotter analysis, and IHC | |
| circ-MYBL2 | miR-361-3p | – | The expression of circ-MYBL2 was significantly upregulated and positively associated with advanced FIGO stage, larger tumor size, lymph node metastasis, and poor prognosis in CC patients | qRT-PCR and Western blotting | |
| hsa_circ_0075341 | miR-149-5p | AURKA | The expression of hsa_circ_0075341 was significantly upregulated and associated with larger tumor size, advanced FIGO stage, and lymph-node metastasis in CC patients | qRT-PCR, IHC, and Kaplan-Meier curves | |
| hsa_circ_0001038 | miR-337-3p | CNNM3, MACC1 | Hsa_circ_0001038 highly expressed in CC tissues and was closely related to lymph node invasion and myometrial invasion | qRT-PCR, Western blotting, Kaplan-Meier curves, Fisher’s exact test, and Pearson correlation analysis | |
| circRNA8924 | miR-518d-5p/519-5p | CBX8 | The level of circRNA8924 expression was significantly correlated with tumor size, FIGO staging and myometrial invasion, but it has no correlation with patient’s age or tumor differentiation or lymph node metastasis | qRT-PCR and Western blotting | |
| circ_0000388 | miR-337-3p | TCF-12 | The circ_0000388 expression was notably correlated with the FIGO stage, lymph node metastasis, and depth of invasion | qRT-PCR and Western blotting | |
| circ_103973 | miR-335 | PPP6C | Higher levels of circ_103973 were correlated to a worse prognosis of CC patients | qRT-PCR | |
| circRNA_0000285 | – | FUS | CircRNA_0000285 expression was significantly higher in CC tissue samples | qRT-PCR | |
| Hsa_circRNA_ 101996 | miR-8075 | TPX2 | The expression level of hsa_circRNA_101996 in CC tissues was positively correlated with TNM stage, tumor size, and lymph node metastasis | qRT-PCR and Kaplan-Meier analysis | |
| circular RNA_0018289 | – | – | Circ_0018289 expression was positively correlated with pathological grade, tumor size, lymph node metastasis, and FIGO stage | RT-qPCR, ROC analysis, and Cox’s regression analysis | |
| circular FoxO3a | – | – | Low serum circFoxO3a levels to be a poor prognostic factor for both OS and RFS, independent of positive lymph node metastasis | RT-qPCR, Kaplan-Meier analysis, and multivariate Cox regression analysis | |
| circZFR | – | SSBP1/CDK2/cyclin E1 | CircZFR was positively associated with lymphatic metastasis and was not associated with age, tumor stage, invasion depth, or vascular invasion | qRT-PCR and ROC analysis |